Sign In
Buy ALZN
$1.31
-0.0400 (-2.96%)
At Close: Jul 31, 2026
Penny Stocks To Buy According To 5 Analysts With 55%-246% Targets
11:24am, Tuesday, 14'th Dec 2021
5 penny stocks analysts say are a buy right now with hefty price targets. The post Penny Stocks To Buy According To 5 Analysts With 55%-246% Targets appeared first on Penny Stocks to Buy, Picks, News
Best Penny Stocks To Buy? 5 To Watch With Potential Catalysts This Week
10:52am, Sunday, 12'th Dec 2021
5 penny stocks to watch this week The post Best Penny Stocks To Buy? 5 To Watch With Potential Catalysts This Week appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Are These Penny Stocks on Your Watchlist This Week?
06:30pm, Sunday, 14'th Nov 2021
Check these penny stocks out for your watchlist this week The post Are These Penny Stocks on Your Watchlist This Week? appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.
Best Biotech Penny Stocks to Buy in November? 3 to Watch Now
09:45am, Monday, 08'th Nov 2021
Which biotech penny stocks are you watching this month? The post Best Biotech Penny Stocks to Buy in November?
ALZN Stock: Why Is Little-Known Alzamend Neuro Gaining Today?
02:00pm, Friday, 05'th Nov 2021
Today, investors in preclinical biotech company Alzamend Neuro and ALZN stock are seeing impressive gains of more than 25% currently. The post ALZN Stock: Why Is Little-Known Alzamend Neuro Gaining To
ALZN Stock Price: Why It Substantially Increased Today
05:34pm, Thursday, 30'th Sep 2021
The stock price of Alzamend Neuro Inc (NASDAQ: ALZN) increased by 35.09% today. This is why it happened.
See Why Alzamend Neuro Stock Is Rallying On Thursday
01:45pm, Thursday, 30'th Sep 2021
Alzamend Neuro Inc (NASDAQ: ALZN) has received a written response to its meeting request regarding the FDA's Type B Pre‑Investigational New Drug (Pre-IND) application. Today's response provides a
ALZN Stock: The Alzheimer's Clinical Trial News That Has Alzamend Neuro Soaring Today
12:32pm, Thursday, 30'th Sep 2021
Alzamend Neuro (ALZN) stock is on the move Thursday after getting an update from the U.S. Food and Drug Administration (FDA). The post ALZN Stock: The Alzheimer's Clinical Trial News That Has Alzamend
Why Alzamend Neuro Shares Are Surging Higher Today
11:54am, Thursday, 30'th Sep 2021
Alzamend Neuro Inc (NASDAQ: ALZN) is surging higher Thursday after the company announced it received a written response to its meeting request relating to its Type B Pre‑IND application from the FD
Here's Why Alzamend Neuro Stock Is Shooting Higher Today
12:44pm, Friday, 23'rd Jul 2021
There's never been a better time to be a mouse with Alzheimer's disease.
ALZN Stock Increases Over 75% Pre-Market: Why It Happened
08:01am, Friday, 23'rd Jul 2021
The stock price of Alzamend Neuro Inc (NASDAQ: ALZN) increased by over 75% pre-market. This is why it happened.
Alzamend Neuro Stock Shoots Higher As Alzheimer's Candidate Shows Encouraging Safety Profile In Animal Models
07:20am, Friday, 23'rd Jul 2021
Alzamend Neuro Inc (NASDAQ: ALZN) has announced positive toxicology results for AL002 in a toxicology study using a transgenic mouse model of Alzheimer's disease. Charles River Laboratories condu
Alzamend Neuro, Inc. to Ring Nasdaq Opening Bell Today
06:00am, Monday, 12'th Jul 2021
TAMPA, Fla.--(BUSINESS WIRE)---- $ALZN #505b2--Alzamend Neuro, Inc. to Ring Nasdaq Opening Bell Today at 9:15am ET; Alzamend Celebrates Successful Initial Public Offering and Corporate Milestone
Alzamend Neuro Submits IND Application For Alzheimer's-Related Dementia Candidate
11:23am, Thursday, 01'st Jul 2021
Ault Global Holdings Inc (NYSE: DPW), a diversified holding company, has announced that Alzamend Neuro Inc (NASDAQ: ALZN) has submitted an investigational new drug application to the FDA for a Ph
Why Alzamend Neuro Stock Popped Today
03:59pm, Monday, 28'th Jun 2021
There wasn't an obvious catalyst for this recent IPO stock.
